Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Lee

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Oncogene|May 11, 2004
CCND1 polymorphism and age of onset of hepatoblastomaSamart Pakakasama, Tina T-L Chen, William Frawley, et al.
Gynecologic Oncology|May 3, 2011
A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group StudyRobert S Mannel, Mark F Brady, Elise C Kohn, et al.
Gynecologic Oncology|December 26, 2008
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group studyHoward D Homesley, Virginia Filiaci, Susan K Gibbons, et al.
Pain Medicine (Malden, Mass.)|January 27, 2021
Diversity of Pain Medicine Trainees and Faculty in the United States: A Cross-Sectional Analysis of Fellowship Training from 2009-2019Charles A Odonkor, Brooks Leitner, Salam Taraben, et al.
Human Molecular Genetics|January 29, 2010
Genetic studies on the functional relevance of the protein prenyltransferases in skin keratinocytesRoger Lee, Sandy Y Chang, Hung Trinh, et al.
The Journal of Biological Chemistry|January 31, 2008
A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cellsCatherine Coffinier, Sarah E Hudon, Roger Lee, et al.
Journal of Lipid Research|September 2, 2008
Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndromeBrandon S J Davies, Shao H Yang, Emily Farber, et al.
The EMBO Journal|June 14, 2021
Phosphoproteomic identification of ULK substrates reveals VPS15-dependent ULK/VPS34 interplay in the regulation of autophagyThomas John Mercer, Yohei Ohashi, Stefan Boeing, et al.
Human Molecular Genetics|April 21, 2009
Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotidesLoren G Fong, Timothy A Vickers, Emily A Farber, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Oncogene|May 11, 2004
CCND1 polymorphism and age of onset of hepatoblastomaSamart Pakakasama, Tina T-L Chen, William Frawley, et al.
Gynecologic Oncology|May 3, 2011
A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group StudyRobert S Mannel, Mark F Brady, Elise C Kohn, et al.
Gynecologic Oncology|December 26, 2008
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group studyHoward D Homesley, Virginia Filiaci, Susan K Gibbons, et al.
Pain Medicine (Malden, Mass.)|January 27, 2021
Diversity of Pain Medicine Trainees and Faculty in the United States: A Cross-Sectional Analysis of Fellowship Training from 2009-2019Charles A Odonkor, Brooks Leitner, Salam Taraben, et al.
Human Molecular Genetics|January 29, 2010
Genetic studies on the functional relevance of the protein prenyltransferases in skin keratinocytesRoger Lee, Sandy Y Chang, Hung Trinh, et al.
The Journal of Biological Chemistry|January 31, 2008
A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cellsCatherine Coffinier, Sarah E Hudon, Roger Lee, et al.
Journal of Lipid Research|September 2, 2008
Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndromeBrandon S J Davies, Shao H Yang, Emily Farber, et al.
The EMBO Journal|June 14, 2021
Phosphoproteomic identification of ULK substrates reveals VPS15-dependent ULK/VPS34 interplay in the regulation of autophagyThomas John Mercer, Yohei Ohashi, Stefan Boeing, et al.
Human Molecular Genetics|April 21, 2009
Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotidesLoren G Fong, Timothy A Vickers, Emily A Farber, et al.
Pageof 5